2005 Meeting Home

      Scientific Program

      Venue/Travel Info

      Support/Exhibition

      Photo Galleries

      Student Stipends

      Past Meetings

      Society Home

The field of in vivo cellular and molecular imaging is emerging with new approaches that reveal aspects of biology in the living body, far beyond that of cancer, that were until recently inaccessible to investigation. The rapidly evolving imaging technologies to be described at the Fourth Annual Meeting of the Society for Molecular Imaging are designed to reveal biological changes in vivo, and thus can be used to improve the study of biology and disease, accelerate the development of new therapeutic approaches and expand the use of these technologies to a wide range of disciplines.

The meeting environment was one where we discussed imaging broadly, and included talks and discussion in areas of biology, chemistry, clinical imaging, genomics, technical advancements and industrial applications. New insights into mammalian biology that have been realized through imaging were a key focus of the meeting. The goal was by the end of the meeting for the participants to have gained a greater understanding of the current status of the field, to leave this meeting with new ideas and the potential for making broad collaborations outside of their specific areas and to appreciate the future of cellular and molecular studies in the living body.

Educational Objectives & CME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the International Society for Magnetic Resonance in Medicine (ISMRM) and the Society for Molecular Imaging. The ISMRM is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement:
The International Society for Magnetic Resonance in Medicine designates this continuing medical education activity for up to 24 hours in Category 1 of the Physician's Recognition Award of the American Medical Association. Each physician should claim only those hours of credit actually spent in the educational activity.

Disclosure:
The Society for Molecular Imaging and the International Society for Magnetic Resonance in Medicine have a policy regarding disclosure of financial relationships. It requires speakers, co-chairs, committee members and poster presenters to disclose whether or not they have financial interests or affiliations with organizations with an interest in the subject matter of their presentations. This information will be provided in the final program book a matter of information for the audience.

Who Should Attend?
The intended audience consists of researchers, clinical practitioners, trainees and other professionals in radiology, neuroradiology, neuroscience, oncology, nuclear medicine, cardiology, medical physics, cell biology, molecular biology, genetics, immunology and medical imaging equipment companies.

Educational Objectives:
Upon completion of this meeting, participants should be able to:
1. Explain methods of target identification and probe development for disease targets.
2. Describe current state-of-the-art detection and outcome measures for cancer and neurodegenerative disorders.
3. Compare data from various molecular imaging modalities that demonstrate significant advantages of different imaging strategies.
4. Evaluate the potential of new imaging methods to detect disease early in its course and recognize when there is the potential for improved outcome.
5. Describe the new imaging paradigms in drug discovery and development.
6. Recommend imaging and therapy combinations.
7. Appraise imaging in the development of cellular and gene therapy.

On behalf of the Scientific Program Committee, we invite you to join us for this exciting event in in vivo discovery.

MEETING CHAIRMAN:
Dr. Thomas Meade, Northwestern University, Evanston, USA

MEETING CO-CHAIRMAN:
Dr. Andreas Jacobs, University of Cologne, Germany

STEERING COMMITTEE:
Dr. Silvio Aime, University of Torino, Torino, Italy
Dr. James Basilion, Massachusetts General Hospital, Charlestown, USA
Dr. Darryl Bornhop, Vanderbilt University, Nashville, USA
Dr. June-Key Chung, Seoul National University Hospital, Seoul, Korea
Dr. Katherine Ferrara, University of California, Davis, USA
Dr. Yasuhisa Fujibayashi, University of Fukui, Fukui, Japan
Dr. Juri Gelovani, UT MD Anderson Cancer Center, Houston, USA
Dr. Ren-Shyan Liu, National Yang-Ming Unversity Medical School, Taipei, Taiwan
Dr. Chrit Moonen, Universite Victor Segalen Bordeaux, France
Dr. David Piwnica-Worms, Washington University School of Medicine, St. Louis, USA
Dr. Eva Sevick-Muraca, Texas A&M University, College Station, USA
Dr. Bertrand Tavitian, European Molecular Imaging Laboratories, CEA, Orsay, France
Dr. Ralph Weissleder, Massachusetts General Hospital, Charlestown USA

SCIENTIFIC PROGRAM COMMITTEE:
Dr. Ronald Blasberg, Memorial Sloan-Kettering Cancer Center, USA
Dr. Thomas Budinger, University of California, Berkeley, Berkeley, USA
Dr. Jeff Bulte, Johns Hopkins University, Baltimore, USA
Dr. Simon Cherry, University of California, Davis, Davis, USA
Dr. John Clark, Wolfsom Brain Imaging Center, Cambridge, UK
Dr. Christopher Contag, Stanford University School of Medicine, Stanford, USA
Dr. William Eckelman, Molecular Tracer, LLC, Bethesda, USA
Dr. Benjamin Franc, University of California, San Francisco, San Francisco, USA
Dr. Joseph A. Frank, National Institutes of Health
Dr. Carlos F.G.C. Geraldes, University of Coimbra, Portugal
Dr. Robert Gillies, University of Arizona, Tucson USA
Dr. Uwe Haberkorn, University of Heidelberg, Germany
Dr. Leonard Hofstra, University Hospital Maastricht, Maastricht, Netherlands
Dr. Alan P. Koretsky, National Institutes of Health
Dr. Peter Lassota, Novartis Pharmaceuticals Corporation, East Hanover, USA
Dr. Clemens Lowik, Leiden University Medical Center, Leiden, Netherlands
Dr. André E. Merbach, Ecole polytechnique fédérale de Lausanne, Switzerland
Dr. Jagat Narula, University of California, Irvine, USA
Dr. Vasilis Ntziachristos, Massachucetts General Hospital, Charlestown, USA
Dr. Joop Peters, Technische Universiteit Delft, Netherlands
Dr. David W. Piston, Vanderbilt University
Dr. Martin G. Pomper, Johns Hopkins University
Dr. Alnawaz Rehemtulla, University of Michigan, Ann Arbor, USA
Dr. Jorge Ripoll, FORTH, Greece
Dr. Brian Ross, University of Michigan, Ann Arbor, USA
Dr. Michael Schäfers, Universitätsklinikum Münster, Germany
Dr. Jan Schnitzer, Sidney Kimmel Cancer Center, San Diego, USA
Dr. Markus Schwaiger, Nuklearmedizinische Klinik
Dr. Henry VanBrocklin, Lawrence Berkeley National Laboratory, Berkeley, USA
Dr. Annemie van der Linden, University of Antwerp, Belgium
Dr. Michael Verneris, University of Minnesota, Minneapolis, USA
Dr. Samuel Wickline, Washington University School of Medicine, St. Louis, USA

The Society for Molecular Imaging
PO Box 293878
Kerrville, TX 78029-3878 USA
1-830-257-0112; Fax: 1-830-257-0119

Executive Director
Joan Oefner
email: joefner@molecularimaging.org

Administrator
Charles Metzger
email: cmetzger@molecularimaging.org